Reprogramming the Monocyte-to-Macrophage Axis: Steering Cell Fate to Resolve Chronic Inflammation & Fibrosis

Time: 11:30 am
day: Conference Day Two

Details:

• Modulating monocyte differentiation to favor anti-inflammatory macrophage phenotypes in chronic disease settings
• Targeting cell fate decisions to disrupt pro-fibrotic macrophage programming
• Therapeutic strategies for durable macrophage reprogramming in inflammation and fibrosis

Speakers:

Leslie Nangle Dr. Leslie Nangle leads research efforts at aTyr Pharma, where since she has helped build a discovery platform focused on extracellular tRNA synthetases and immune Read more